Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALOGLIPTIN vs SAXAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALOGLIPTIN vs SAXAGLIPTIN: Safety Overview

Metric ALOGLIPTIN SAXAGLIPTIN
Total FAERS Reports 1,385 2,468
Deaths Reported 122 263
Death Rate 8.8% 10.7%
Hospitalizations 567 838
Average Patient Age 69.0 yrs 65.5 yrs
% Female Patients 41.0% 47.8%
FDA Approval Date Jan 25, 2013 Jul 31, 2009
Manufacturer Padagis Israel Pharmaceuticals Ltd Glenmark Pharmaceuticals Inc., USA
Route ORAL ORAL
Marketing Status Prescription Discontinued